NASDAQ : BBIO
BridgeBio Pharma, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 74.95 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 14.65B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
BridgeBio Pharma, Inc. (BBIO) reported revenue of 945.54M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 945.54M | 502.08M | 221.90M | 9.30M | 77.65M | 69.72M |
| Cost of Revenue | 53.54M | 20.96M | 3.88M | 2.45M | 3.43M | 3.11M |
| Gross Profit | 892.00M | 481.11M | 218.02M | 6.86M | 74.21M | 66.60M |
| Selling, General & Admin | 709.10M | 531.23M | 288.93M | 150.59M | 143.19M | 188.91M |
| Research & Development | 536.01M | 451.95M | 506.46M | 455.71M | 399.46M | 451.02M |
| Operating Expenses | 1.25B | 983.18M | 795.39M | 606.30M | 542.65M | 639.93M |
| Operating Income | -353.11M | -502.06M | -577.37M | -599.44M | -468.44M | -573.33M |
| Interest Expense | -213.29M | -178.24M | -99.29M | -81.29M | -80.44M | -46.78M |
| Interest & Investment Income | 30.34M | 19.85M | 17.25M | 18.04M | 7.54M | 1.13M |
| Earnings From Equity Investments | -60.83M | -72.61M | -31.18M | |||
| Other Non Operating Income (Expenses) | 31.54M | 43.06M | 4.14M | -944.00K | 102.43M | 3.70M |
| EBT Excluding Unusual Items | -565.34M | -690.00M | -686.46M | -663.64M | -438.90M | -615.28M |
| Merger & Restructuring Charges | -11.13M | -21.35M | -15.33M | -7.93M | -43.77M | |
| Gain (Loss) on Sale of Investments | 8.14M | 18.31M | -8.22M | 29.91M | ||
| Gain (Loss) on Sale of Assets | 178.32M | -6.26M | ||||
| Asset Writedown | -271.00K | -3.30M | ||||
| Other Unusual Items | -21.16M | -26.59M | 12.50M | 2.21M | ||
| Pretax Income | -576.47M | -732.50M | -542.19M | -653.25M | -484.65M | -586.45M |
| Income Tax Expense | 1.11M | 435.00K | 1.15M | |||
| Earnings From Continuing Operations | -577.58M | -732.94M | -543.35M | -653.25M | -484.65M | -586.45M |
| Minority Interest in Earnings | 11.74M | 8.01M | 7.58M | 10.05M | 3.47M | 23.91M |
| Net Income | -565.83M | -724.93M | -535.76M | -643.20M | -481.18M | -562.54M |
| Net Income to Common | -592.12M | -724.93M | -535.76M | -643.20M | -481.18M | -562.54M |
| Shares Outstanding (Basic) | 195.05M | 191.53M | 186.08M | 162.79M | 147.47M | 144.36M |
| Shares Outstanding (Diluted) | 195.05M | 191.53M | 186.08M | 162.79M | 147.47M | 144.36M |
| EPS (Basic) | -3.04 | -3.78 | -2.88 | -3.95 | -3.26 | -3.90 |
| EPS (Diluted) | -3.04 | -3.78 | -2.88 | -3.95 | -3.26 | -3.90 |
| Free Cash Flow | -369.81M | -447.01M | -521.66M | -529.03M | -424.31M | -511.18M |
| Free Cash Flow Per Share | -1.90 | -2.33 | -2.80 | -3.25 | -2.88 | -3.54 |
| Gross Margin | 94.34% | 95.83% | 98.25% | 73.71% | 95.58% | 95.53% |
| Operating Margin | -37.34% | -100.00% | -260.19% | -6,443.56% | -603.28% | -822.38% |
| Profit Margin | -62.62% | -144.39% | -241.44% | -6,913.92% | -619.70% | -806.90% |
| Free Cash Flow Margin | -39.11% | -89.03% | -235.08% | -5,686.62% | -546.46% | -733.23% |
| EBITDA | -348.36M | -496.63M | -571.29M | -592.95M | -461.67M | -567.49M |
| EBITDA Margin | -36.84% | -98.91% | -257.45% | |||
| D&A For EBITDA | 4.74M | 5.43M | 6.08M | 6.49M | 6.77M | 5.84M |
| EBIT | -353.11M | -502.06M | -577.37M | -599.44M | -468.44M | -573.33M |
| EBIT Margin | -37.34% | -100.00% | -260.19% | |||
| Revenue as Reported | 945.54M | 502.08M | 221.90M | 9.30M | ||
| Advertising Expenses | 110.10M | 21.50M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.53B | 570.12M | 681.10M | 375.94M | 376.69M | 393.77M |
| Short-Term Investments | 5.49M | 17.36M | 58.95M | 95.23M | 442.89M | |
| Cash & Short-Term Investments | 1.54B | 587.48M | 681.10M | 434.88M | 471.92M | 836.66M |
| Accounts Receivable | 375.09M | 139.44M | 4.72M | 1.75M | 17.08M | 19.75M |
| Receivables | 375.09M | 139.44M | 4.72M | 1.75M | 17.08M | 19.75M |
| Inventory | 59.72M | 26.75M | ||||
| Prepaid Expenses | 69.39M | 38.42M | 31.04M | 24.30M | 21.92M | 32.27M |
| Restricted Cash | 550.00K | 550.00K | 126.00K | 16.65M | 37.93M | 177.00K |
| Other Current Assets | 1.00M | 5.10M | 3.70M | |||
| Total Current Assets | 2.04B | 797.75M | 720.69M | 477.59M | 548.85M | 888.86M |
| Property, Plant & Equipment | 20.79M | 13.52M | 12.78M | 19.84M | 25.25M | 45.97M |
| Long-Term Investments | 47.78M | 79.97M | 143.75M | 1.60M | ||
| Other Intangible Assets | 25.92M | 28.08M | 23.93M | 26.32M | 28.71M | 44.93M |
| Other Long-Term Assets | 22.69M | 16.71M | 18.20M | 21.02M | 20.22M | 33.03M |
| Total Assets | 2.16B | 936.02M | 919.34M | 546.38M | 623.04M | 1.01B |
| Accounts Payable | 88.26M | 36.23M | 9.62M | 10.65M | 11.56M | 11.88M |
| Accrued Expenses | 320.14M | 238.36M | 124.08M | 116.97M | 95.54M | 116.75M |
| Current Portion of Long-Term Debt | 548.43M | |||||
| Current Portion of Leases | 1.99M | 6.19M | 4.51M | 4.13M | 3.67M | 4.94M |
| Current Unearned Revenue | 4.74M | 7.19M | 14.60M | 6.10M | 8.16M | |
| Other Current Liabilities | 13.68M | 1.59M | 6.00M | 2.50M | 1.50M | |
| Total Current Liabilities | 977.24M | 287.97M | 154.40M | 143.84M | 121.43M | 135.07M |
| Long-Term Debt | 2.81B | 1.85B | 1.72B | 1.73B | 1.71B | 1.70B |
| Long-Term Leases | 14.64M | 3.81M | 4.70M | 8.98M | 12.27M | 17.43M |
| Long-Term Unearned Revenue | 8.97M | 13.08M | 17.09M | 3.73M | 7.10M | |
| Other Long-Term Liabilities | 1.41M | 855.27M | 479.38M | 5.63M | 19.54M | 22.07M |
| Total Liabilities | 3.82B | 3.01B | 2.38B | 1.89B | 1.87B | 1.88B |
| Common Stock | 207.00K | 202.00K | 196.00K | 181.00K | 157.00K | 154.00K |
| Additional Paid-In Capital | 2.17B | 2.06B | 1.90B | 1.48B | 938.70M | 841.53M |
| Retained Earnings | -4.19B | -3.82B | -3.10B | -2.56B | -1.92B | -1.44B |
| Treasury Stock | -580.77M | -323.28M | -275.00M | -275.00M | -275.00M | -275.00M |
| Comprehensive Income & Other | -95.00K | 12.00K | 8.00K | 31.00K | -328.00K | -132.00K |
| Total Common Equity | -2.60B | -2.09B | -1.47B | -1.35B | -1.25B | -870.41M |
| Minority Interest | 8.84M | 10.03M | 10.29M | 11.72M | 9.69M | 4.83M |
| Shareholders' Equity | -1.65B | -2.08B | -1.46B | -1.34B | -1.24B | -865.58M |
| Total Liabilities & Equity | 2.16B | 936.02M | 919.34M | 546.38M | 623.04M | 1.01B |
| Total Debt | 3.38B | 1.86B | 1.73B | 1.74B | 1.72B | 1.73B |
| Net Cash (Debt) | -1.84B | -1.27B | -1.05B | -1.30B | -1.25B | -889.51M |
| Net Cash Per Share | -9.43 | -6.66 | -5.64 | -8.02 | -8.49 | -6.16 |
| Filing Date Shares Outstanding | 194.80M | 193.86M | 190.19M | 175.83M | 151.37M | 147.61M |
| Total Common Shares Outstanding | 196.00M | 194.77M | 190.04M | 175.08M | 150.63M | 147.34M |
| Working Capital | 1.07B | 509.78M | 566.29M | 333.75M | 427.43M | 753.79M |
| Book Value Per Share | -13.29 | -10.71 | -7.72 | -7.73 | -8.33 | -5.91 |
| Tangible Book Value | -2.63B | -2.11B | -1.49B | -1.38B | -1.28B | -915.35M |
| Tangible Book Value Per Share | -13.42 | -10.86 | -7.85 | -7.89 | -8.52 | -6.21 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -565.83M | -724.93M | -535.76M | -643.20M | -481.18M | -562.54M |
| Depreciation & Amortization | 4.74M | 5.43M | 6.08M | 6.49M | 6.77M | 5.84M |
| Other Amortization | 7.12M | 5.97M | 7.46M | 8.91M | ||
| Loss (Gain) From Sale of Assets | -178.32M | 1.24M | 6.26M | |||
| Asset Writedown & Restructuring Costs | 12.72M | |||||
| Loss (Gain) From Sale of Investments | -8.14M | -18.31M | 8.22M | -29.91M | ||
| Loss (Gain) on Equity Investments | 51.99M | 63.77M | 31.18M | |||
| Stock-Based Compensation | 151.81M | 133.02M | 95.80M | 108.71M | 91.56M | 99.50M |
| Other Operating Activities | 142.72M | 121.89M | 28.93M | 3.39M | -91.92M | -6.43M |
| Change in Accounts Receivable | -258.57M | -134.72M | -2.97M | 15.33M | 15.17M | -19.75M |
| Change in Inventory | -37.59M | -25.31M | ||||
| Change in Accounts Payable | 69.52M | 26.61M | 1.51M | 2.78M | -349.00K | 2.83M |
| Change in Unearned Revenue | -8.51M | -11.43M | 21.88M | -5.44M | 15.26M | |
| Change in Other Net Operating Assets | 73.63M | 93.78M | 11.63M | -7.61M | -2.00M | 12.52M |
| Operating Cash Flow | -368.97M | -445.91M | -520.73M | -527.72M | -419.49M | -497.93M |
| Capital Expenditures | -835.00K | -1.10M | -933.00K | -1.31M | -4.82M | -13.25M |
| Sale of Property, Plant & Equipment | 10.00M | |||||
| Cash Acquisitions | 13.65M | |||||
| Divestitures | -140.00K | -503.00K | ||||
| Sale (Purchase) of Intangibles | -8.49M | -7.97M | -1.50M | -35.00M | ||
| Investment in Securities | -1.76M | -17.20M | 44.15M | 55.84M | 339.47M | -166.23M |
| Other Investing Activities | 2.30M | 25.68M | 110.00M | |||
| Investing Cash Flow | -2.59M | -24.49M | 60.78M | 54.03M | 453.15M | -200.83M |
| Long-Term Debt Issued | 875.00M | 950.00M | 1.20B | |||
| Long-Term Debt Repaid | -459.00M | -473.42M | -20.49M | -124.12M | ||
| Net Debt Issued (Repaid) | 576.89M | 416.00M | 476.58M | -20.49M | 1.08B | |
| Issuance of Common Stock | 56.65M | 34.15M | 322.90M | 459.22M | 8.08M | 20.46M |
| Repurchase of Common Stock | -273.36M | -62.50M | -7.53M | -6.88M | -1.56M | -204.75M |
| Other Financing Activities | -29.43M | -28.35M | -43.50M | -801.00K | 837.00K | -158.95M |
| Financing Cash Flow | 1.26B | 359.29M | 748.46M | 451.54M | -13.13M | 736.45M |
| Net Cash Flow | 890.39M | -111.10M | 288.51M | -22.15M | 20.52M | 37.69M |
| Free Cash Flow | -369.81M | -447.01M | -521.66M | -529.03M | -424.31M | -511.18M |
| Free Cash Flow Margin | -39.11% | -89.03% | -235.08% | -5,686.62% | -546.46% | -733.23% |
| Free Cash Flow Per Share | -1.90 | -2.33 | -2.80 | -3.25 | -2.88 | -3.54 |
| Levered Free Cash Flow | -287.13M | -325.29M | -291.12M | -240.16M | -285.88M | -301.13M |
| Unlevered Free Cash Flow | -160.95M | -219.86M | -236.53M | -198.26M | -235.61M | -271.89M |
| Cash Interest Paid | 43.13M | 43.67M | 91.34M | 61.11M | 54.44M | 29.77M |
| Cash Income Tax Paid | 1.20M | 1.20M | ||||
| Change in Working Capital | -161.53M | -51.06M | 32.04M | 5.06M | 28.08M | -4.40M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 14.73B | 14.74B | 5.19B | 7.02B | 1.14B | 2.46B |
| Enterprise Value | 16.57B | 16.80B | 6.66B | 8.23B | 2.27B | 3.26B |
| Last Close Price | 74.95 | 76.49 | 27.44 | 40.37 | 7.62 | 16.68 |
| PS Ratio | 15.39 | 29.36 | 23.37 | 754.92 | 14.67 | 35.22 |
| PB Ratio | -7.10 | -3.56 | -5.23 | -0.92 | -2.84 | |
| EV/Sales Ratio | 17.34 | 33.46 | 30.02 | 884.51 | 29.25 | 46.81 |
| Debt / Equity Ratio | -2.04 | -0.90 | -1.19 | -1.30 | -1.38 | -1.99 |
| Net Debt / Equity Ratio | -1.11 | -0.61 | -0.72 | -0.97 | -1.00 | -1.03 |
| Net Debt / EBITDA Ratio | -5.28 | -2.57 | -1.84 | -2.20 | -2.71 | -1.57 |
| Net Debt / FCF Ratio | -4.97 | -2.85 | -2.01 | -2.47 | -2.95 | -1.74 |
| Asset Turnover | 0.60 | 0.54 | 0.30 | 0.02 | 0.10 | 0.08 |
| Quick Ratio | 1.96 | 2.52 | 4.44 | 3.04 | 4.03 | 6.34 |
| Current Ratio | 2.09 | 2.77 | 4.67 | 3.32 | 4.52 | 6.58 |
| Return on Assets (ROA) | -13.97% | -33.83% | -49.24% | -64.08% | -35.80% | -41.75% |
| Return on Capital Employed (ROCE) | -29.80% | -77.50% | -75.50% | -148.90% | -93.40% | -65.30% |
| Earnings Yield | -4.02% | -4.92% | -10.33% | -9.16% | -42.24% | -22.91% |
| FCF Yield | -2.54% | -3.03% | -10.06% | -7.53% | -37.25% | -20.82% |
| Buyback Yield / Dilution | -2.39% | -2.93% | -14.30% | -10.39% | -2.16% | -22.34% |